I am seeing it plain as day also. I was trying to suggest that the OSA trial results are the company maker, rather than short term negative sentiment. I came to the same conclusions as yourself as i have been closely tracking the actions of the BOD since the trial finished and was handed to Novotech.
In saying that please keep up your content and great posts. You perfectly sum up the validation that the BOD is giving the OSA trial.
IHL Price at posting:
50.0¢ Sentiment: Buy Disclosure: Held